๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
To evaluate the efficacy and safety of short-course radiotherapy followed b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT07059949
Treatments Being Tested
Primary liver cancer is the second most common cause of cancer death in Chi...
Status
Unknown
Location
Multiple Locations
Start Date
2021-09-01
Trial ID
NCT04947956
Treatments Being Tested
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
This is a multicenter phase II clinical study to explore the efficacy, safe...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-04-30
Trial ID
NCT06869226
Treatments Being Tested
This is a prospective single-arm exploratory clinical study. The efficacy a...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2023-08-01
Trial ID
NCT05624099
Treatments Being Tested
The study is being conducted to evaluate the efficacy, safety and tolerabil...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2025-06-08
Trial ID
NCT07026149
Treatments Being Tested
This prospective trial aims to enroll patients with stage III-IVA (AJCC 8th...
Status
Recruiting
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Start Date
2024-07-30
Trial ID
NCT06675214
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study evaluated the effectiveness and safety of Camrelizumab combinati...
Status
Unknown
Location
Sichuan Cancer Hospital & Institute
Start Date
2021-12-21
Trial ID
NCT05472467
Treatments Being Tested